Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
about
Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related ConditionsWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersCurrent and potential pharmacological treatments for obsessive-compulsive disorderSelective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?Sertraline in the treatment of anxiety disorders.Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorderObsessions: the impact and treatment of obsessive-compulsive disorder in children and adolescents.Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations.More than Medication-Achieving Goals through Psychotherapy in Patients with Obsessive Compulsive Disorder.Management of anxiety disorders: the added challenge of comorbidity.Evidence-based pharmacotherapy of obsessive-compulsive disorder.Anxiety disorders and major depression, together or apart.The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs.From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient SamplesPharmacotherapies in the management of obsessive-compulsive disorder.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Pharmacotherapy of anxious disorders.Childhood anxiety disorders and developmental issues in anxiety.Current management of obsessive and phobic states.Dosing of Selective Serotonin Reuptake InhibitorsPharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic AgentsA review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation.Minority participation in randomized controlled trials for obsessive-compulsive disorder.Where does obsessive-compulsive disorder belong in DSM-V?Management of obsessive-compulsive disorder with fluvoxamine extended releaseFive-year course of obsessive-compulsive disorder: predictors of remission and relapse.Treatment strategies for obsessive-compulsive disorder.A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cellsPsychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports.Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder.CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.
P2860
Q22241102-F2EC5ECF-2747-4139-8FFF-F3657567F47DQ22305681-D380F2FE-23D9-450A-97B1-804ADBDE75FAQ22306025-87DA5D12-4ECB-41B7-BB08-5B39AB133880Q24242402-1F5B77F4-E3B6-440C-989E-313D08891533Q32097605-A2984B53-E683-4A8B-830C-289BB93AADBAQ33183862-985730A2-CE7C-4B7F-B0E7-F659B4FA72D7Q33898364-13EEEBA6-5AEB-4401-BCB4-80A2884F424FQ33914087-CD47D0E0-A76C-4150-9D19-824924222A47Q33926476-DA584BB1-741C-45AE-98FF-62ED0C882C91Q33963431-E5B11B45-39D1-4972-9D23-F314C20F7F3DQ34066108-08F4AD7F-8594-4E80-825B-74EEA2C00EAAQ34068960-8F33ABB4-43B7-44B5-921D-E72911104FAFQ34218830-32CCE8BD-FA86-418E-9CDF-34C2EA4DA64EQ34245428-8A1857E9-FDBC-4AB9-8BE1-09DBD1774654Q34415535-ADFAB823-2E93-49E4-A4C5-05508F14829DQ34525841-9C137198-3756-4B47-A154-B444E1ABCC04Q34546238-4D3571C8-4A84-4DE1-AD50-01A287D6324AQ34547177-6268CD21-6936-4836-B50A-6F0B02F06244Q34865036-093F69DD-8DF8-4DCB-913A-814D330C01EDQ35011794-DCFD56F1-8C55-4832-AFCB-2AB5BB410AA3Q35176158-E08BCBCA-AD58-4F36-860A-BE3F8B679B0AQ35327098-688D53E3-0C93-41F1-9A54-84D4D5BF8ABFQ35666956-6CF61188-D85D-4ABC-99C1-B18EE790816BQ35752941-9369F6C6-9682-4CF0-AEF7-0852BA254BFDQ35936259-D871A818-202A-42A4-83AC-CD0BCC6C8AE2Q36200991-4C3F4449-3E95-41FE-8447-8630F29B57DDQ37138385-3A9EC9AA-831A-419C-9E76-A3F895AD8259Q37235709-A9488E69-3AAC-4833-B0EE-D5D5FE7F2248Q37506023-2A753E4A-0B73-4998-BBB0-805BD81F8CA5Q37681560-75421DE8-3279-4939-98BD-F2B2F478D929Q38004948-C2FCD991-706B-4006-A504-E0AE649F91ABQ38057736-18ED73AD-21E8-4998-B972-197410F4C17DQ38207094-8D4C8505-91DC-429F-BF45-D101AC622EFCQ39143491-57E73247-D9E3-4F66-B9FB-214B0939610BQ40240452-EAFC9758-C6EA-4B6D-BB97-ABDBEBFF116EQ41025805-98C683D8-8301-4666-BDE3-DBF5A14A651BQ44098828-A08B8EC4-664E-4CA3-902F-68329FE1F311Q45189223-34C3F612-E9C3-4461-9FC9-00B408AE3C8EQ46611107-0115E8A3-8743-4D69-A057-36BD965F7CA3Q47127372-82FB9BD1-D95C-4AF9-A10C-4A520976E7CD
P2860
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@ast
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@en
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@nl
type
label
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@ast
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@en
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@nl
prefLabel
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@ast
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@en
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@nl
P2093
P1433
P1476
Double-blind parallel comparis ...... obsessive-compulsive disorder.
@en
P2093
Chouinard G
Liebowitz M
Lydiard RB
Rasmussen S
P304
P356
10.1001/ARCHPSYC.1995.03950160039008
P407
P577
1995-04-01T00:00:00Z